Cartesian Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RNAC and other ETFs, options, and stocks.About RNAC
Cartesian Therapeutics, Inc. operates as a clinical-stage biotechnology company. It provides mRNA cell therapies for the treatment of autoimmune diseases.
RNAC Key Statistics
Stock Snapshot
With a market cap of 179.16M, Cartesian Therapeutics(RNAC) trades at $6.88. The stock has a price-to-earnings ratio of -0.15.
On 2026-03-05, Cartesian Therapeutics(RNAC) stock traded between a low of $6.86 and a high of $7.90. Shares are currently priced at $6.88, which is +0.3% above the low and -12.9% below the high.
The Cartesian Therapeutics(RNAC)'s current trading volume is 223.65K, compared to an average daily volume of 150.89K.
In the last year, Cartesian Therapeutics(RNAC) shares hit a 52-week high of $18.80 and a 52-week low of $5.98.
In the last year, Cartesian Therapeutics(RNAC) shares hit a 52-week high of $18.80 and a 52-week low of $5.98.
Analyst ratings
86%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.